| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.4 |
| Infectious disease | R-HSA-5663205 | 4.47 |
| Toxicity of botulinum toxin type A (BoNT/A) | R-HSA-5250968 | 10.98 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.81 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.73 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.89 |
| Toxicity of botulinum toxin type C (BoNT/C) | R-HSA-5250971 | 11.4 |
| Toxicity of botulinum toxin type E (BoNT/E) | R-HSA-5250992 | 11.4 |
| Integration of energy metabolism | R-HSA-163685 | 6.24 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.46 |
| Metabolism | R-HSA-1430728 | 2.34 |
| Neurotransmitter Release Cycle | R-HSA-112310 | 7.34 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.66 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.81 |
| Neuronal System | R-HSA-112316 | 4.82 |
| Regulation of insulin secretion | R-HSA-422356 | 6.66 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.28 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.28 |
| Disease | R-HSA-1643685 | 3.33 |